TCL Archive FDA Grants Six-Month Priority Review To Nolvadex For DCIS Adjuvant Treatment. March 31, 2000
TCL Archive Also in this 8-page Issue: Safety Warnings Are Added to Labels for Epo and Avastin. January 21, 2005
TCL Archive FDA Advisors Uphold Broad Mandate To Limit Use Of ESA Products In Cancer Indications. May 11, 2007